By Sneha S K May 5 (Reuters) - Lab equipment maker Waters raised its annual profit forecast on Tuesday after beating quarterly estimates, driven by robust demand for drug development tools and the strong performance of its biosciences and diagnostics unit, acquired last year. Shares of the company were up 12.7% at $340.13. Waters supplies lab equipment and technology across the world, with the majority of its revenue coming from biopharma client…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.